Clinical Trials Browser

OTHER × Leiomyoma × gadoterate meglumine × Clear all

NCT01514617 2024-07-10

Diffusion -and Perfusion Weighted MRI for Response Prediction of Symptomatic Leiomyomas Following Uterine Artery Embolization

Phase NA Active not recruiting

Leiomyoma